A Ph2b to Evaluate Tildacerfont in the Reduction of Glucocorticoid Steroid Doses in Adult CAH

Clinical trial NCT04544410 · TERMINATED

Trial details

NCT number: NCT04544410
Sponsor: Spruce Biosciences
Status: TERMINATED
Phase: Phase 2
Study type: INTERVENTIONAL

Congenital Adrenal Hyperplasia

Start date: 2021-02-22
Primary completion: 2024-10-31
Enrollment: 100

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.